These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35182969)

  • 1. Epithelial cell adhesion molecule (EpCAM) binding short peptides derived from antibody MOC-31; De-novo design, synthesis and their in-vitro evaluation.
    Shinde SD; Rao KB; Behera SK; Arya N; Sahu B
    Biochem Biophys Res Commun; 2022 Apr; 600():1-5. PubMed ID: 35182969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM
    Nicolazzo C; Gradilone A; Loreni F; Raimondi C; Gazzaniga P
    Dis Markers; 2019; 2019():1718920. PubMed ID: 31636732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capture of Tumor Cells on Anti-EpCAM-Functionalized Poly(acrylic acid)-Coated Surfaces.
    Andree KC; Barradas AM; Nguyen AT; Mentink A; Stojanovic I; Baggerman J; van Dalum J; van Rijn CJ; Terstappen LW
    ACS Appl Mater Interfaces; 2016 Jun; 8(23):14349-56. PubMed ID: 27187784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell adhesion molecule independent capture of non-small lung carcinoma cells with peptide modified microfluidic chip.
    Pu K; Li C; Zhang N; Wang H; Shen W; Zhu Y
    Biosens Bioelectron; 2017 Mar; 89(Pt 2):927-931. PubMed ID: 27818051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients.
    Hekimian K; Stein EL; Pachmann U; Pachmann K
    Clin Chem Lab Med; 2012 Dec; 50(4):701-8. PubMed ID: 22505561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wash-free and selective imaging of epithelial cell adhesion molecule (EpCAM) expressing cells with fluorogenic peptide ligands.
    K C TB; Suga K; Isoshima T; Aigaki T; Ito Y; Shiba K; Uzawa T
    Biochem Biophys Res Commun; 2018 Jun; 500(2):283-287. PubMed ID: 29660346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the Roles of Pro-Metastatic EpCAM in Cancer.
    Mohtar MA; Syafruddin SE; Nasir SN; Low TY
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32046162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).
    Myung JH; Launiere CA; Eddington DT; Hong S
    Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
    Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
    Takao M; Nagai Y; Torii T
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.
    Kim MJ; Choi NY; Lee EK; Kang MS
    Cell Oncol (Dordr); 2014 Aug; 37(4):235-43. PubMed ID: 25001871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of an EpCAM-targeting cyclic peptide to improve the EpCAM-mediated cellular internalization and tumor accumulation of a peptide-fused antibody.
    Park SW; Jun SY; Kim JS; Kim YS
    Biochem Biophys Res Commun; 2021 Oct; 573():35-41. PubMed ID: 34388452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.